- Home
- RDN vs LEGN Comparison
RDN vs LEGN Comparison
Compare RDN & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDN
- LEGN
- Stock Information
- Founded
- RDN 1977
- LEGN 2014
- Country
- RDN United States
- LEGN United States
- Employees
- RDN N/A
- LEGN N/A
- Industry
- RDN Property-Casualty Insurers
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- RDN Finance
- LEGN Health Care
- Exchange
- RDN Nasdaq
- LEGN Nasdaq
- Market Cap
- RDN 4.6B
- LEGN 5.4B
- IPO Year
- RDN 1992
- LEGN 2020
- Fundamental
- Price
- RDN $33.84
- LEGN $38.96
- Analyst Decision
- RDN Hold
- LEGN Strong Buy
- Analyst Count
- RDN 7
- LEGN 12
- Target Price
- RDN $36.57
- LEGN $73.91
- AVG Volume (30 Days)
- RDN 1.4M
- LEGN 1.6M
- Earning Date
- RDN 07-30-2025
- LEGN 08-08-2025
- Dividend Yield
- RDN 3.02%
- LEGN N/A
- EPS Growth
- RDN 4.01
- LEGN N/A
- EPS
- RDN 3.92
- LEGN N/A
- Revenue
- RDN $1,288,979,000.00
- LEGN $728,303,000.00
- Revenue This Year
- RDN N/A
- LEGN $65.49
- Revenue Next Year
- RDN $2.30
- LEGN $53.76
- P/E Ratio
- RDN $8.62
- LEGN N/A
- Revenue Growth
- RDN 3.11
- LEGN 112.46
- 52 Week Low
- RDN $29.32
- LEGN $27.34
- 52 Week High
- RDN $37.86
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- RDN 40.51
- LEGN 66.26
- Support Level
- RDN $35.38
- LEGN $34.64
- Resistance Level
- RDN $36.81
- LEGN $39.88
- Average True Range (ATR)
- RDN 0.70
- LEGN 1.46
- MACD
- RDN -0.28
- LEGN 0.37
- Stochastic Oscillator
- RDN 4.54
- LEGN 87.67
About RDN Radian Group Inc.
Radian Group Inc is engaged in mortgage and real estate services. It provides both credit-related mortgage insurance coverage and other products and services across the residential real estate and mortgage finance industries. It has one business segment Mortgage Insurance. The Mortgage Insurance segment aggregates, manages, and distributes U.S. mortgage credit risk for the benefit of mortgage lending institutions and mortgage credit investors, through private mortgage insurance on residential first-lien mortgage loans, and also offers other credit risk management solutions, including contract underwriting, to customers. It also provides other mortgage and real estate products and services through Mortgage Conduit, Title, Real Estate Services, and Real Estate Technology businesses.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.